Table 2 Distribution of molecular variables analysed in whole population
Characteristic | TOT = 155 |
|---|---|
N (%) | |
CDX2 | |
Low | 47 (32.6%) |
Intermediate | 50 (34.8%) |
High | 47 (32.6%) |
NEa | 11 |
CK7 | |
Low | 81 (87.1%) |
High | 12 (12.9%) |
NE | 9 |
Not tested | 53 |
CK20 | |
Low | 11 (11.8%) |
High | 82 (88.2%) |
NEa | 9 |
Not tested | 53 |
CMS | |
1 | 44 (39.7%) |
2–3 | 47 (42.3%) |
4 | 20 (18.0%) |
NEa | 44 |
TILs | |
Low | 61 (39.6%) |
High | 93 (60.4%) |
NEa | 1 |
Barras et al. subtypes | |
BM1 | 51 (49%) |
BM2 | 53 (51%) |
NEa | 51 |
Clinical prognostic scoreb | |
Low | 69 (44.8%) |
Intermediate | 59 (38.3%) |
High | 26 (16.9%) |
NEa | 1 |
